• Rare Element Resources makes two board appointments
    Rare Element Resources (CVE:RES) reported Wednesday that it has appointed Paul Schlauch as director of the company and Norman Anderson as non-executive chairman. Paul Schlauch replaces Stephen Quin as director. Quin stepped down to lead the development of a new gold project in the United States.... More »
    Jul. 15, 2011 RES
  • Strong Earnings Reports Propel U.S. Equity Futures Higher
    This morning.  The four major indexes experienced distribution days yesterday, and the U.S. equity market uptrend remains under pressure.  The SPX and NYSE composite both closed below their respective 50-day moving averages.  In Asia, equity markets closed mixed, on generally... More »
    Jul. 15, 2011 FHN, C, JPM
  • Fundamental analysis of Sirus XM (part 3)
    See part 1See part 2 This article is the final part of my analysis of Sirius XM. In the previous valuation, certain assumptions were made to determine a cap the potential Sirius XM model by determining the state of maturity of its current business platform. Additionally, the assigned... More »
    Jul. 15, 2011 SIRI
  • Nextraction doubles land holding in Provost oil play, sees jump in production
    Canadian junior oil and gas company Nextraction Energy Corp. (CVE:NE) said Thursday that it has boosted its leasehold position in its Provost Viking oil pool in Alberta by almost double, and reported a ten-fold increase in production from its first vertical well frac. The company acquired one... More »
    Jul. 15, 2011 NE
  • Between Hope and Fear
    Daily State of the Markets Friday Morning - July 15, 2011 Good morning. During times of uncertainty in the market, the major indices have a tendency to seek an equilibrium point between hope and fear. With so many big, bad events on the horizon, it appears that this is what is occurring at... More »
    Jul. 15, 2011
  • NeoStem to acquire Amorcyte and phase 2 cardiovascular therapy candidate
    NeoStem (AMEX:NBS) announced Thursday it plans to acquire Amorcyte, a development stage cell therapy company focused on cardiovascular disease, whose lead product is AMR-001, currently about to start a phase two study for the treatment of acute myocardial infarction (AMI). The acquisition will... More »
    Jul. 15, 2011
  • Distribution Disturbs - July 15, 2011
    The Wagner Daily - July 15, 2011 Concise technical analysis and picks of the leading global ETFs Commentary: Stocks fell across the board on brisk trade. All five major indices closed down on the session. The small-cap Russell 2000 led the plunge as it fell 1.5%. In a similar exhibition of... More »
    Jul. 15, 2011 EIDO, EPU
  • Gender Diversity 'Free Lunch' Factor in Bottom-Up Investment Selection?
    The New 'Free Lunch' DiversificationNobel Prize Laureate dr Harry Markowitz (Nobel Prize 1990) taught us that diversification can create value by reducing risk levels more than that returns will suffer when combining different investments ranging from high-return, high-risk to lower-return,... More »
    Jul. 15, 2011
  • Fundamental Analysis of Sirius XM (part 2)
    See part 1 This article is the second part of my analysis of Sirius XM. In the first part it was conjured that cash flow is the single most important performance metric of the company. The most important aspect of the business model is the operational leverage, as fixed costs are high and... More »
    Jul. 15, 2011 SIRI
  • Google's Earnings May Spark Rally, 4 Positions
    A new report has been posted on the Selective Chartists website.Click on the URL attachment to open the report.  If you have any difficulties, please e-mail us... More »
    Jul. 15, 2011